Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.
2001
Dermatomyositis with parenchymal lung involvement.
1972
Anti-C5 Antibody Treatment Ameliorates Weakness in Experimentally Acquired Myasthenia Gravis
2007
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
2011
Supportive Care for Patients With Guillain-Barré Syndrome
2005
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
2001 Standout
Plasmapheresis in Myasthenia Gravis
1987
The Membrane Attack Complex of Complement at the Endplate in Myasthenia Gravisa
1987
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
2000 Standout
Myasthenia Gravis
1988
Myasthenia Gravis
2016 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
1996 Standout
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
2010 Standout
Thymectomy for NonthymomatousMyasthenia Gravis
2008
Induced Pluripotent Stem Cells: Past, Present, and Future
2012 StandoutNobel
Myasthenia gravis associated with etanercept therapy
2009
The role of autophagy in neurodegenerative disease
2013 Standout
Muscle specific kinase autoimmune myasthenia gravis in children: A case series
2013
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Diagnosis and treatment of Parkinson disease: molecules to medicine
2006
Thymoma
1993
Autoimmunity in Stiff‐Man Syndrome with breast cancer is targeted to the C‐terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161
1994
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease
2003
Outcomes of thoracoscopic thymectomy in patients with juvenile myasthenia gravis
2016
Concentric‐needle single‐fiber electromyography for the diagnosis of myasthenia gravis
2006
Guillain-Barré syndrome
2016 Standout
Interstitial lung disease in polymyositis and dermatomyositis
2000
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Guillain–Barré Syndrome
2012 Standout
The genetics and neuropathology of Parkinson’s disease
2012
A Broken α-Helix in Folded α-Synuclein
2003 StandoutNobel
Radioimmunoassay for Glutamic Acid Decarboxylase (GAD65) Autoantibodies as a Diagnostic Aid for Stiff-Man Syndrome and a Correlate of Susceptibility to Type 1 Diabetes Mellitus
1998
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Stiff-Person Syndrome
2004
Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis
2004
Parkinson's disease
2009 Standout
Rare genetic mutations shed light on the pathogenesis of Parkinson disease
2003
Familial Dementia With Lewy Bodies
2002
A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in ‘antibody-negative’ myasthenia gravis
1990
Endoplasmic reticulum stress: cell life and death decisions
2005 Standout
Myasthenia Gravis
1994 Standout
The stiff man and stiff man plus syndromes
1999
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Protein aggregation and neurodegenerative disease
2004 Standout
PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism
2004
Frequency of seronegativity in adult‐acquired generalized myasthenia gravis
2007
Parkinson's disease
2015 Standout
Autoantibodies to a 128-kd Synaptic Protein in Three Women with the Stiff-Man Syndrome and Breast Cancer
1993
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Ubiquitin–proteasome system and Parkinson's disease
2006
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
An ice test for the diagnosis of myasthenia gravis
1999
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
2004
HERPES ZOSTER MYELITIS
1991
Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated
1992
The neuropathology of genetic Parkinson's disease
2012
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Experience with intravenous immunoglobulin in myasthenia gravis
1989
AAEE minimonograph #33: Electrodiagnostic approach to defects of neuromuscular transmission
1989
Myasthenia gravis: past, present, and future
2006
Diagnostic sensitivity of the laboratory tests in myasthenia gravis
1992
Parkinson's disease and α‐synuclein expression
2011
Humoral Pathogenesis of Myasthenia Grayisa
1987
Nanoscale organization of nicotinic acetylcholine receptors revealed by stimulated emission depletion microscopy
2006 StandoutNobel
Ocular myasthenia: diagnostic and treatment recommendations and the evidence base
2008
Differentialdiagnose des Ischiasschmerzes aus neurologischer Sicht
1997
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
2005
Alpha-synuclein and neurodegenerative diseases
2001
Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies
2000
Varicella zoster virus infection
2015
IgG4-related disease
2014 Standout
Advances in the Diagnosis of Neuromuscular Junction Disorders
2005
α-synuclein locus duplication as a cause of familial Parkinson's disease
2004 Standout
Thymectomy as Primary Therapy in Myasthenia Gravis
1987
Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor–reactive T cells
1990
A common LRRK2 mutation in idiopathic Parkinson's disease
2005 Standout
Extraocular Muscle Susceptibility to Myasthenia Gravis
2008
Guidelines for treatment of autoimmune neuromuscular transmission disorders
2010
Herpes Zoster
2013 Standout
Polymyositis and dermatomyositis
2003 Standout
Update on juvenile myasthenia gravis
2013
Herpes Zoster
2002 Standout
Autoimmunity to Gephyrin in Stiff-Man Syndrome
2000
Amyotrophic Lateral Sclerosis
2001 Standout
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Paraneoplastic syndromes of the spinal cord, nerve, and muscle
2000
Guillain-Barré syndrome
2005 Standout
Parkinson's Disease
2003 Standout
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
1990
Polymyositis and Dermatomyositis
1975 Standout
Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability
1999
A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
2013
Pulmonary Hypertension in Polymyositis
1981
Rare genetic mutations shed light on the pathogenesis of Parkinson disease
2003
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) [RETIRED]
2000
Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation
2001
1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla
1999
Genetic Analysis of Default Mating Behavior in Saccharomyces cerevisiae
1997 StandoutNobel
Thymectomy for non-thymomatous myasthenia gravis
2013
The heart and cardiac conduction system in polymyositis-dermatomyositis: A clinicopathologic study of 16 autopsied patients
1982
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS: CELLULAR AND HUMORAL IMMUNE RESPONSES*
1976
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Risk factors for subarachnoid hemorrhage.
1985
Clinical Characteristics of Pediatric Myasthenia: A Surveillance Study
2013
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer
1978
Polymyositis and Dermatomyositis
1975 Standout
MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITY
1986
Complement activation in muscle fiber necrosis: Demonstration of the membrane attack complex of complement in necrotic fibers
1982
Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR
2020 StandoutNobel
Factors Affecting Survivorship in Polymyositis. A Life‐Table Study of 124 Patients
1971
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: Diagnosis and management approaches
1983
Myasthenia gravis
1984
Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets.
1987 StandoutNobel
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Intracellular free calcium as a pathogen in cell damage initiated by the immune system
1981
Maximum Thymectomy for Myasthenia Gravis
1987
Thymectomy in myasthenia with pure ocular symptoms.
1985
Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases.
1987
Multifocal varicella‐zoster virus leukoencephalitis temporally remote from herpes zoster
1981
Autoantibody Profiles and Neurological Correlations of Thymoma
2004
Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor
1987
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Herpes zoster: A possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals
1986
The Office Tensilon Test for Ocular Myasthenia Gravis
1986
Works of F Howard being referenced
Hereditary form of parkinsonism—dementia
1998
Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravisa
1987
Stiff-Man Syndrome Updated
1989
Striational Autoantibodies: Quantitative Detection by Enzyme Immunoassay in Myasthenia Gravis, Thymoma, and Recipients of d-Penicillamine or Allogeneic Bone Marrow
1988
Lancaster Red-Green Test in Evaluation of Edrophonium Effect in Myasthenia Gravis
1969
The Otolaryngologic Presentation of Amyotrophic Lateral Sclerosis
1978
The Value of Thymectomy in Myasthenia Gravis
1976
Respiratory failure in Guillain-Barré syndrome: a 6-year experience.
1982
ALTERNATE‐DAY PREDNISONE: PRELIMINARY REPORT OF A DOUBLE‐BLIND CONTROLLED STUDY*
1976
Polymyositis and Dermatomyositis
1960
Myasthenia gravis in children: Long‐term follow‐up
1983
Thymectomy in Juvenile Myasthenia Gravis
1971
Ultrastructural Localization of the Terminal and Lytic Ninth Complement Component (C9) at the Motor End-plate in Myasthenia Gravis
1980
Spinal cord vascular malformations with symptoms during menstruation
1977
Segmental zoster paresis—a disease profile
1972
Laboratory tests in polymyositis.
1966
Three Types of Pulmonary Involvement in Polymyositis
1964
The laboratory diagnosis of mild myasthenia gravis
1982
Plasmapheresis in the Treatment of Ventilator-Dependent Myasthenia Gravis Patients
1984